Vycor Medical, Inc. (VYCO)

Market Cap	3.84M
Revenue (ttm)	1.69M
Net Income (ttm)	-439.53K
Shares Out	33.37M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,111
Average Volume	3,990
Open	0.0876
Previous Close	0.1000
Day's Range	0.0876 - 0.1150
52-Week Range	0.0325 - 0.5000
Beta	-0.44
RSI	47.91
Earnings Date	Aug 13, 2025

About Vycor Medical

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: VYCO

Financial Performance

In 2024, Vycor Medical's revenue was $1.59 million, an increase of 8.81% compared to the previous year's $1.46 million. Losses were -$431,570, 9.52% more than in 2023.